News Focus
News Focus
icon url

arvitar

08/27/16 9:15 AM

#123895 RE: BioChica #123893

The company first has to identify a lead candidate for IND-enabling studies, which they have not done yet.

Next, the company has to do all the chemistry and toxicology testing on that candidate, to get an approved IND application. That takes about a year in the most optimistic case, and 60%-70% of candidates fail this process.

Refer to the FDA timelines and probabilities, provided below for everyone's convenience, for an accurate estimate of how long things will take:

http://www.fdareview.org/03_drug_development.php

icon url

JG36

08/27/16 11:10 PM

#123912 RE: BioChica #123893

Good grief. Phase I trials can't be done until tox is done.
Tox on Herpescide can't be done until NNVC has selected a candidate to test.

The best we can hope for is that NNVC will select a candidate by the end of this year. That's all they say they hope to do in their SEC filings. Given that we have no evidence that any samples have been sent to universities to test, it will be surprising if NNVC even gets that far.

NNVC has never got anything through tox. There's no reason to believe that Herpescide will be the Great Exception.